SEARCH RESULTS FOR: 仿制AT(189 results)

Coach's First Aid Kit- (15) Adhesive Plastic Bandages 3/4" x 3", (20) Junior Adhesive Plastic Bandages 3/8" x 1-1/2", (3) Adhesive Plastic Bandages 1" x 3", (15) Adhesive Spot Bandages 7/8"x7/8", (1) Knuckle Fabric Bandage, (1) Fingertip Fabric Bandage, (1) Elbow/Knee Adhesive Bandage, (2) Butterfly Wound Closures, (1) Triangular Bandage 4"x 4"x 5", (2) Sterile Gauze Pads 2"x2", (1) Pressure Bandage 2"x 2", (1) Pressure Bandage 3"x 3", (1) First Aid Tape Roll 1/2"x2.5yds, (1) Instant Ice Pack, (2) Alcohol Cleansing Pads, (4) Antiseptic Towelettes, (1) CPR Breathing Barrier, (1) Emergency First Aid Guide, (6) Assorted Safety Pins, (2) Medical Grade Vinyl Gloves, (1) Burn Cream, (1) Triple Antibiotic Ointment 0.9g, (10) Cotton Tipped Applicators, (1) Blood Stopper Dressing, (1) Sterile Eye Pad, (1) Sterile Eye Wash 10ml, (2) Chewable Aspirin Tablets

The Access SARS-CoV-2 IgM is a paramagnetic particle, chemiluminescent immunoassay intended for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum, serum separator tubes and plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, sodium citrate). The Access SARS-CoV-2 IgM is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. The Access SARS-CoV-2 IgM should not be used to diagnose acute SARS-CoV-2 infection. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests. The Access SARS-CoV-2 IgM assay is only for use under the Food and Drug Administration's Emergency Use Authorization.

The Access SARS-CoV-2 IgG II assay is a paramagnetic particle, chemiluminescent immunoassay intended for the semi-quantitative and qualitative detection of IgG antibodies to SARS-CoV-2 in human plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, and sodium citrate). The Access SARS-CoV-2 IgG II assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. The Access SARS-CoV-2 IgG II should not be used to diagnose or exclude acute SARS-CoV-2 infection. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests. The Access SARS-CoV-2 IgG II assay is only for use under the Food and Drug Administration's Emergency Use Authorization.

Test Cassettes (25), Extraction Buffer Tubes (25), Nasal Swabs (25)

Test Cassettes (5), Extraction Buffer Tubes (5), Nasal Swabs (5)

Test Cassettes (2), Extraction Buffer Tubes (2), Nasal Swabs (2)

Test Cassette (1), Extraction Buffer Tube (1), Nasal Swab (1)

Test Cassettes (25), 2.5mL Buffer Bottles (2), Droppers (25)

1 Test per kit (L03A-R0645):Test Cassette (1), Extraction Buffer Tube (1), Nasal Swab (1); 2 Test per kit (L03A-R0745): Test Cassettes (2), Extraction Buffer Tubes (2), Nasal Swabs (2); 5 Test per kit (L03A-R0845): Test Cassettes (5), Extraction Buffer Tubes (5), Nasal Swabs (5); 25 Test per kit (L03A-R0945): Test Cassettes (25), Extraction Buffer Tubes (25), Nasal Swabs (25)